WOODBURY, Minn.--(BUSINESS WIRE)--Kindeva Drug Delivery, a global leader in contract drug delivery development and manufacturing services and technology, and H&T Presspart (a division of the Heitkamp ...
Patients with PH-ILD in the US have access to only one approved therapy, while no therapies to treat PH-ILD are approved outside of the US. Gossamer and Chiesi plan to initiate a Phase 3 study in ...
Chiesi Group proudly shares its contribution to the thought-provoking series "The Climate and Us", presented by the Global Climate and Health Alliance and produced for them by BBC StoryWorks. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results